
BPOM Issues Emergency Use Authorization for Zifivax Vaccine
On Thursday (07/10), the Food and Drug Monitoring Agency (BPOM) issued an Emergency Use Authorization (EUA) for Zifivax COVID-19 vaccine developed by Anhui Zhifei Longcom Biopharmaceutical with a recombinant protein subunit platform. The Zifivax vaccine is recommended for people aged 18 years and older for the prevention of SARS-CoV-2 that causes COVID-19. The vaccine is […]